Belviq Recall Cancer Lawsuit
The Food and Drug Administration (FDA) has recommended a recall of all lots of Belviq and Belviq XR from the U.S. market after a clinical study found an increase in the occurrence of cancer among users. The cancers linked to Belviq include lung cancer, pancreatic cancer, and colorectal cancer. Belviq (lorcaserin) is a prescription weight loss drug originally approved by the FDA in 2012.
If you or a loved one has been diagnosed with cancer after taking Belviq or Belviq XR, contact one of our Minnesota Cancer Lawyers today. Our team has been representing victims of corporate negligence for over 30 years and will deliver the Gold standard advocacy you deserve.
Call 800-903-1643 >Case Quick Facts
On February 13, 2020, the FDA issued a safety communication requesting the recall of the prescription weight loss drug Belviq. The recall is based on a clinical study that showed an increase in the occurrence of certain cancers among Belviq users.
The clinical study was mandated by the FDA to analyze the risk of cardiovascular problems associated with Belviq use. The study evaluated 12,000 patients over five years and found that 7.7 percent of patients taking Belviq were diagnosed with cancer. Only 7.1 percent of patients taking a placebo over the same time period were diagnosed with cancer. The occurrence of cancer among patients taking Belviq increased with a longer duration of use.
The results compelled the FDA to alert the public of the possible cancer increase associated with Belviq in January 2020, but at that time the agency did not recommend removing the drug from the market. Less than a month later, the FDA concluded that the potential risk of cancer outweighs the benefits of the drug and recommended the manufacturer recall Belviq from the U.S. Market. The agency is advising all patients to stop taking Belviq and all healthcare providers to stop prescribing it.
You should immediately consult with your doctor before discontinuing any medication.
The five year clinical study of Belviq found in increase in several types of cancer among users, including:
- Lung Cancer
- Colorectal cancer
- Pancreatic cancer
Belviq was developed by Arena Pharmaceuticals and approved for use in the U.S. market in 2012. The rights to the drug were sold to Eisai Inc. in 2017, and Eisai continued to manufacture the drug for U.S. consumption until the FDA-recommended recall in February 2020.
GoldenbergLaw is currently investigating cases where an individual has taken Belviq and developed cancer. We have been litigating complex cancer cases for over thirty years and will fight to bring you the justice you deserve.
Contact us today for a free consultation.
Do I Qualify?
A Personal Message From Senior Partner Stuart Goldenberg
In the past two years we have seen two of the largest FDA recalls in history due to drugs contaminated with cancer-causing agents. Sadly, the news that Belviq has been recalled due to cancer risks is just another instance of a system that prioritizes profits over people. Too often, the rush to get a new drug onto the market takes precedence over a thorough evaluation of that drug’s safety and efficacy. As pharmaceutical corporations line their pockets, patients suffer. At GoldenbergLaw, we have worked tirelessly for over three decades to right the wrongs of an unfair system. Let us do the heavy lifting as you focus on your treatment and recover. Leave the sleepless nights to us.
Call 800-903-1643
Belviq Lawsuit FAQs
If you have taken Belviq or Belviq XR and been diagnosed with lung cancer, pancreatic cancer, or colorectal cancer, you may have a case against the manufacturers. Contact GoldenbergLaw today for a free evaluation of a Belviq cancer lawsuit.
Belviq was recalled after a clinical study found increased occurrences of certain cancers associated with long term use of the drug. Cancers associated with Belviq use include lung cancer, pancreatic cancer, and colorectal cancer.
Yes. The Belviq recall includes all lots of Belviq and Belviq XR sold in the U.S. market.
No. If you are currently taking Belviq, the FDA has recommended that you stop taking the drug immediately and speak with your healthcare provider about alternative treatments.
On February 13, 2020, the FDA issued a statement requesting Eisai Inc. recall all lots of Belviq and Belviq XR from the U.S. market. The Belviq recall came after the FDA evaluated findings from a clinical study that showed an increased risk of instances of certain cancers among long term users of the drug. More information on the FDA’s Belviq recall can be found here.
If you have been diagnosed with cancer after using Belviq, you may be entitled to compensation for your injuries. Contact GoldenbergLaw for a free consultation and to learn more about a Belviq recall lawsuit.
Free Consultations
If you or a loved one developed lung cancer, pancreatic cancer, or colorectal cancer after taking Belviq, contact GoldenbergLaw today for a complementary consultation. We have decades of experience litigating cancer cases and believe strongly in promoting safety through accountability.
Contact Us Call 800-903-1643Why Choose GoldenbergLaw?
Our Belviq cancer lawsuit attorneys have over thirty years of experience representing victims of corporate negligence. Let us deliver the Gold standard advocacy you deserve.
Thousands of Successful Settlements
Comprehensive Knowledge of Complex Issues
